Companies / ImageneBio, Inc.

ImageneBio, Inc.

Nasdaq: IMACIK 1835579SAN DIEGO, CA

Financials · FY2025

Revenue$800.0K
Net income$-45.35M
Total debt$0
Cash$94.68M
Diluted EPS$-9.64
Shares outstanding11.4M

Ownership

11.4M shares outstanding · as of Jul 31, 2026
0.75%Insiders
Ownership
Insiders0.75%85,400
Institutions45.20%5,130,547
Public float54.05%6,135,509

% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.

Insiders 8

View all →
Insider% of sharesShares
Yarema KristinCEOChief Executive Officer · Director
0.75%85,400
Butler ErinFormerPrincipal Accounting Officer
0.23%25,551
Orbimed Advisors LLCFormerDirector
——
OrbiMed Capital GP VI LLCFormerDirector
——
OrbiMed Genesis GP LLCFormerDirector
——
Porter-Brown BenjaminFormerChief Medical Officer
——
Slattery Joseph PDirector
——
Stampacchia OtelloDirector
——

Institutional holders 41

View all →
HolderValue% of shares
Blue Owl Capital Holdings LP$5.68M7.26%
Bvf INC/IL$5.55M9.78%
Cable Car Capital, LP$4.44M5.67%
Omega Fund Management, LLC$3.14M4.01%
RTW Investments, LP$2.31M2.95%
Orbimed Advisors LLC$1.89M3.33%
Vanguard Group Inc$1.64M2.10%
BML Capital Management, LLC$1.18M1.77%
BlackRock, Inc.$797.0K1.19%
Monashee Investment Management LLC$632.2K0.81%

Activity

View all →
InsidersInstitutions
What insiders are doing in this stock (Form 4).
DateActorActionSecurityValueShares ΔPosition afterImpact
Mar 16, 2026Yarema Kristin
CEO
GrantCommon Stock$0+85K
85,400
0.75% of shares
low
Dec 30, 2025Butler Erin
Executive
GrantCommon Stock$0+23K
+737.46%
25,551
0.23% of shares
low
Jun 16, 2026Stampacchia Otello
Director
GrantStock Option (right to buy)—+16K
15,600
0.14% of shares
low
Jun 16, 2026Slattery Joseph P
Director
GrantStock Option (right to buy)—+16K
15,600
0.14% of shares
low
Apr 14, 2026Orbimed Advisors LLC
Director
BuyPre-Funded Warrants (right to buy)—+385K
384,689
3.39% of shares
low
Apr 14, 2026Orbimed Advisors LLC
Director
BuyPre-Funded Warrants (right to buy)—+337K
336,603
2.97% of shares
low
Mar 16, 2026Yarema Kristin
CEO
GrantEmployee Stock Option (right to buy)—+128K
128,100
1.13% of shares
low
Dec 30, 2025Butler Erin
Executive
GrantEmployee Stock Option (right to buy)—+23K
22,500
0.20% of shares
low

5%+ ownership events

Schedule 13D / 13G
FilerStance% of classSharesDate
Deep Track Capital, LPPassive13G/A—0—
Funicular Funds, LPPassive13G———
Blue Owl Capital Holdings LPPassive13G———

Securities

via CUSIP / OpenFIGI
SymbolTypeMarketCUSIPFIGI
IMACommon StockEquity45175G207BBG00XZY4TG9